Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00098891What this trial is testingMS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or LymphomasWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+41 more National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT00005639What this trial is testingAzacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous TreatmentWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Not applicableWithdrawnNCT01801670What this trial is testingImpact of Vorinostat on Pruritus Signaling Pathways - Merck StudyWho this might be right forPruritus Boston University
Testing effectiveness (Phase 2)Study completedNCT00007345What this trial is testingDepsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell LymphomaWho this might be right forCutaneous T Cell LymphomaPeripheral T Cell Lymphoma National Cancer Institute (NCI) 131
Not applicableEnded earlyNCT00952185What this trial is testingInfluenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more City of Hope Medical Center 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07658924What this trial is testingEfficacy and Safety of Benvitimod Cream in Cutaneous T-Cell LymphomaWho this might be right forCutaneous T-Cell LymphomaMycosis Fungoides (MF) Peking University First Hospital 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more City of Hope Medical Center 260
Testing effectiveness (Phase 2)Study completedNCT00006345What this trial is testingDexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell LymphomaWho this might be right forDrug/Agent Toxicity by Tissue/OrganLymphoma Ligand Pharmaceuticals
Not applicableStudy completedNCT06113081What this trial is testingReal World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell LymphomaWho this might be right forCutaneous T Cell LymphomaCutaneous T-Cell Lymphoma/Mycosis FungoidesCutaneous T-Cell Lymphoma/Sezary Syndrome Fondazione Italiana Linfomi - ETS 100
Not applicableStudy completedNCT00712556What this trial is testingPET Study in Patients With Non-Hodgkin LymphomaWho this might be right forLymphoma Vanderbilt-Ingram Cancer Center 55
Large-scale testing (Phase 3)Ended earlyNCT01098656What this trial is testingLenalidomide Maintenance Post-debulking in Advanced CTCLWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 21
Early research (Phase 1)Study completedNCT00003970What this trial is testingGenetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+56 more National Cancer Institute (NCI) 60
Early research (Phase 1)Ended earlyNCT01738594What this trial is testingDose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell LymphomaWho this might be right forRecurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides/Sezary SyndromeStage I Cutaneous T-cell Non-Hodgkin Lymphoma+11 more Northwestern University 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT01352520What this trial is testingSGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)Who this might be right forCD-30 Positive Anaplastic Large T-cell Cutaneous LymphomaLymphoma, Primary Cutaneous Anaplastic Large CellLymphomatoid Papulosis+5 more M.D. Anderson Cancer Center 79
Testing effectiveness (Phase 2)Looking for participantsNCT04256018What this trial is testingMogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary SyndromeWho this might be right forSezary SyndromeMycosis Fungoides Stanford University 30
Early research (Phase 1)Study completedNCT01254578What this trial is testingLenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT00003993What this trial is testingBryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institute on Aging (NIA) 24
Testing effectiveness (Phase 2)Looking for participantsNCT05357794What this trial is testingEffectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis FungoidesWho this might be right forMycosis Fungoides M.D. Anderson Cancer Center 30